Co-op, Biologic Therapeutics Discovery and Engineering

Six-month student co-op in Antibody Discovery supporting neurodegenerative disease programs.

perform experiments to characterize and optimize antibody drug candidates, including cell culture, molecular cloning, PCR, qRT-PCR, ELISA, MSD, flow cytometry, and biophysical assays; contribute to nominating lead biologics and validating clinical targets.

pursuing a PhD or Master's in Computational Biology, Bioinformatics, Biochemistry, Immunology, or related; experience with cell culture, molecular biology, protein binding assays, flow cytometry; familiarity with Python, HPC, and machine learning tools preferred.

• antibody therapeutics
• neurodegenerative and neuromuscular indications
• in vitro biophysical and cell-based assays
• computational modeling
• AI/ML skills
• early-stage drug discovery

internship, remote or hybrid, in the U.S., with eligibility to work and enrolled in an accredited program.

Consider building your career as a Co-op, Biologic Therapeutics Discovery and Engineering at Biogen.